Condition: Prostate Cancer · Sponsor: Region Skane
HYPO-RT-PC boost is is an open-label, multicentre, phase II trial evaluating safety and efficacy of real-time image-guided tumor-directed ultra-hypofractionated radiation boost and lymph node irradiation for patients with node-negative high risk localized prostate cancer.
This description comes directly from the study's public registry record.
Adalsteinn Gunnlaugsson, MD, PhD · +46 4617 6268 · Adalsteinn.Gunnlaugsson@skane.se
HYPO-RT-PC boost Clinical Trials Office · +46 4617 8559 · cto.hematologi_onkologi.se@skane.se
Always discuss trial participation with your own doctor first.
| Region Skåne, Skåne University Hospital | Lund, Sweden | Recruiting |
| Region Västerbotten, Umeå University Hospital | Umeå, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06220435